{"name":"CRISM Therapeutics LTD","slug":"crism-therapeutics-ltd","ticker":"","exchange":"","domain":"","description":"CRISM Therapeutics LTD is a biotechnology company focused on developing innovative treatments for cancer, particularly in the area of glioblastoma multiforme (GBM). The company's lead product, irinotecan-ChemoSeed, is in Phase 2 clinical trials and is designed to be implanted into the resection cavity after surgical removal of GBM tumors.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-04","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOQXhGU1Y0WHZrWDBvWnltSTRicGdrVC11RVJCUjYwR3NQXzJKYmJId280bXZBcE9ha3RiUy0xaXNmRDFBOXlITTVCVVcyRWp0NUZKdGF1Mmc0QjJLTHhRc1hLQVg4bkllenc0Z0RKQkdaT2c4TS13dXpjbHNNUzd3OWwyRHowLTZrNzdLc0NocFRaRlUxM2NjemlYcmNrNWJTUkxVYjhRdEtIcGdnRDJUdVo2YTdtcDJkeTVyXw?oc=5","date":"2026-03-25","type":"pipeline","source":"Sharecast.com","summary":"Crism completes manufacture of first ChemoSeed chemical batch - Sharecast.com","headline":"Crism completes manufacture of first ChemoSeed chemical batch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOTjZuWkpxV3lxZlZId2stUEItdk5Xc3MxZVJwRllEREVpQ0RQNU50Ql9pYy1jS3dPYzZrVno3ZmRlcW00VFQ0V3p5V1dFLXY2MTVaSWF5SmNzSzhFSkdyM3VMZlIxOHRrYTFUMzdfMHZ4WHRTalZoSVRzb2pGQzc5M21ncEhvUQ?oc=5","date":"2024-05-31","type":"pipeline","source":"Hargreaves Lansdown","summary":"CRISM Therapeutics Corp Share Price (CRTX) NPV | CRTX - Hargreaves Lansdown","headline":"CRISM Therapeutics Corp Share Price (CRTX) NPV | CRTX","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNNEl1MHU4cVVqZW16bzZHZjk3aU9LVHlmZ1p5Y25jWnN1X3dHZ3BVN3pyNS1iN0ZEUmtPUDBFMjJ4ZmRzcWFPVno5cU1PZG9qUzNJdmw5bVlKcF9sMGRTSUdYRmJiWEtrcFR2Ymc3Y3Q1SDFUdmpfY0JMdncxQlhaOWFDWWM1bFVRdkpJblNqVzVIQQ?oc=5","date":"2024-05-31","type":"pipeline","source":"London South East","summary":"Crism Therapeutics Corp Share Price (AMC.GB.PL) - London South East","headline":"Crism Therapeutics Corp Share Price (AMC.GB.PL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNQjdDaER1emJiMlVzWWl1S0podm12YkExNEFIUXdlZ0RBVXpnM3M2TEdiS0dFZlVZSG5YMldnSmc2Y0dlelFKNVZYdGdCRXlqUzZadTdDMTFMVzRCZV9IdHE1dlFGMjNjWVRQS2FVZFRDQVctcExnazdZWVFsdkxtd2c3YS05a1FsZHpidEFHNzdQRkZiRVd0clBpVkYzS1FhOXVBX1VTMkZhOXJRSDFBWTFjVlJjZmlvZWhQZ19KNVp4OGhFUVFLaTBrY2dNNVduWmxSWXRjWWEtVjRaTmtybjlZRQ?oc=5","date":"2024-05-13","type":"deal","source":"Proactive Investors","summary":"Extruded Pharmaceuticals to make stock market debut after RTO deal with Amur - Proactive Investors","headline":"Extruded Pharmaceuticals to make stock market debut after RTO deal with Amur","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPbXZQX1J1eEdYYzdtdUZOODFkZUlldi1uWUVheDVkQW9nMVRFc2V3SU9mSEU2cWZuNFB5Tmt5S3EwaW1FMzV0NlJJWFMzVnR4dFlwSEtPb3h0aDFfS2JSVU1pY25QVmR4TW80MlQ0VV9rNGU1ejdkdnlzaGNDeHJ0N1VKV3FER0c0QWpNb2s5WXV5TUZ0OEdCMEp4UQ?oc=5","date":"2024-05-13","type":"pipeline","source":"Share Talk","summary":"Amur Minerals Corporation (AIM:AMC, OTC:AMMCF) Proposed Reverse Takeover - Share Talk","headline":"Amur Minerals Corporation (AIM:AMC, OTC:AMMCF) Proposed Reverse Takeover","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNNVZVWGVWd0JMYi1nM3NoOHgzM21iUEQyZVIzT2tJWEVKc3VOZU5aZVJVUTNSOEhOY3UtQVg5NE1BX0VmZ255VWhWbW9KaEhaZHAwU2dLWGt6UE5hZ0x2WFYwZ1FpLUZqek4zNVRrYWdMUjBfYk5xUXM1UFlJcUppVmJPTHZRN2tIX1pTcG5aa2xQZExU?oc=5","date":"2024-04-13","type":"pipeline","source":"The Motley Fool","summary":"3 Magnificent Stocks That Could Double or More by 2030 - The Motley Fool","headline":"3 Magnificent Stocks That Could Double or More by 2030","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}